Copertina

Computer‐Assisted Screening of Active Compounds in Traditional Chinese Medicine Targeting SNX10 as a Promising Treatment for Inflammatory Bowel Diseases

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yongpan An, Bowen Zhang, Yuwei Ye, Xianghong Wang, Chi Zhang, Jianjun Ding, Ke Gao, Yanan Ouyang, Ruixiao Li, Yi Ying, Xiaorong Xue, Guojun Wu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Basic & Clinical Pharmacology & Toxicology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Traditional Chinese Medicine for Inhibiting Ferroptosis in Ischemic‐Related Diseases
di: Yukun Zhang, et al.
Pubblicazione: (2025)

Application of Artificial Intelligence in the Development of Traditional Chinese Medicine
di: Xuebing He, et al.
Pubblicazione: (2025)

Traditional Chinese Medicine in the Treatment of Infertility: A Comprehensive Review
di: Yiman Chen, et al.
Pubblicazione: (2026)

Natural Compounds From Traditional Chinese Medicine Against Doxorubicin‐Induced Cardiotoxicity: Biological Mechanisms and Therapeutic Potential
di: Min Li, et al.
Pubblicazione: (2026)

Traditional Chinese Medicine for Anti‐Arrhythmias: Mechanisms via Potassium Channels
di: Chenhao Gao, et al.
Pubblicazione: (2025)

Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review
di: Faria Sayed, et al.
Pubblicazione: (2025)

Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction
di: Ana M. Briones, et al.
Pubblicazione: (2025)

Xiao‐Jie‐An Capsule Attenuates Oestrogen‐ and Progestogen‐Induced Mammary Gland Hyperplasia by Modulating Sex Hormone Levels and Reducing Inflammatory Response
di: Kecheng Tang, et al.
Pubblicazione: (2026)

The Climate Impact of Medicines in the Hospital Sector: A Scoping Review
di: Katrine Bitsch Johansen, et al.
Pubblicazione: (2026)

Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples
di: Magnus A. B. Axelsson, et al.
Pubblicazione: (2025)

Environmental Aspects in Price and Reimbursement Decisions of Medicines—A Scoping Review
di: Lasse Alajärvi, et al.
Pubblicazione: (2026)

Addressing Improper Medicine Storage Practices: Commentary on Louhisalmi et al.'s Study
di: Shu‐Wen Cheng, et al.
Pubblicazione: (2025)

Electrochemical Point‐of‐Care Test for Assessing Serum Paracetamol Concentration: Comparison With Traditional Methods and Detection of Concomitant Drugs
di: Johanna K. Kujala, et al.
Pubblicazione: (2025)

Assessment of Rivaroxaban Plasma Concentration Using Chromogenic Anti‐Xa Assays and UHPLC–MS/MS in Chinese Patients With Atrial Fibrillation
di: Xiao‐qin Liu, et al.
Pubblicazione: (2025)

PGI Score: A Promising Alternative to Serum Cholinesterase for Predicting Mortality and Adverse Outcomes in Acute Organophosphorus Poisoning: A Cross‐Sectional Study
di: Ghada Attia Sagah, et al.
Pubblicazione: (2025)

Differences in the Inflammatory Response and Corticoid Responsiveness of Human Lung Macrophages and Parenchymal Explants Exposed to Cigarette Smoke Extracts
di: Marion Brollo, et al.
Pubblicazione: (2025)

High Throughput Pharmacovigilance Screening for Roflumilast Adverse Effects in Real‐World Settings: A Sequence Symmetry Analysis
di: Abdullah Abdelaziz, et al.
Pubblicazione: (2025)

Fluvoxamine Inhibited NLRP3 and NF‐κB Inflammatory Pathways and Maintained Genital Functions by Ameliorating CD‐MPR, KISS‐1, AQP4 and Claudin‐1 Expressions
di: Senay Topsakal, et al.
Pubblicazione: (2025)

TCA Cycle Intermediate Mitigates Di(2‐ethylhexyl) Phthalate‐Induced Cholestatic Liver Injury Through Modulation of the Nrf2/NQO1 Signalling Axis
di: Yue Jiang, et al.
Pubblicazione: (2025)

Filgotinib Improves Experimental Pulmonary Fibrosis by Modulating JAK1/STAT3/SOCS3/IL‐17A Signalling
di: Yunying Lv, et al.
Pubblicazione: (2025)

Curcumin Alleviates Myocardial Ischaemia–Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis via the Nrf2/HO‐1 Pathway: An Integrated Network Pharmacology and Experimental Study
di: Lingling Yao, et al.
Pubblicazione: (2026)

S1PR3 Inactivation Aggravates Cerebrovascular Endothelial Cell Permeability Mediated by cPLA 2 and STAT3 Phosphorylation Under Oxidative Stress
di: Junyu Mu, et al.
Pubblicazione: (2026)

Small‐molecule inhibitor HI‐TOPK‐032 improves NK‐92MI cell infiltration into ovarian tumours
di: Mengqi Deng, et al.
Pubblicazione: (2024)

Significant Antispastic Effect of Combined Fasudil and Isosorbide Dinitrate on Internal Mammary Artery in Coronary Artery Bypass Grafting
di: You‐Feng Zhang, et al.
Pubblicazione: (2025)

Paroxetine alleviates ulcerative colitis in mice via restoring intestinal microbiota homeostasis and metabolism
di: Minquan Zhang, et al.
Pubblicazione: (2024)

Bergaptol Alleviates Oxidative Stress and Inflammation in Intracerebral Haemorrhage Mice via JAK2/STAT3 and NF‐κB Pathways, Improving Neurological Function
di: Jianbing Wu, et al.
Pubblicazione: (2025)

A novel approach combining network pharmacology and experimental validation to study the protective effect of ginsenoside Rb1 against cantharidin‐induced hepatotoxicity in mice
di: Lijuan Xiong, et al.
Pubblicazione: (2024)

The Effects of Drugs on CYP3A Enzyme Activity and Protein Expression Through Ubiquitination Modification Regulation
di: Fang Wang, et al.
Pubblicazione: (2025)

Tetrahydroxy Stilbene Glycoside Reduces Abeta Deposition by Modulating Microglia Activation and via TREM2/PI3K/AKT Pathway in APP/PS1 Mice
di: Ming Li, et al.
Pubblicazione: (2025)

IL‐4 promotes chondrogenesis of bone marrow mesenchymal stem cells and blockade of IL‐4Rα retards the endochondral ossification during rat embryonic bone development
di: Yimeng Hao, et al.
Pubblicazione: (2024)

Astragaloside IV Ameliorates Allergic Rhinitis Comorbid With Asthma by Inhibiting the Antigen‐Presenting Function of B Cells
di: Ruizhi Wang, et al.
Pubblicazione: (2026)

Diallyl trisulfide alleviates dextran sulphate sodium‐induced colitis in mice by inhibiting NLRP3 inflammasome activation via ROS/Trx‐1 pathway
di: Yue He, et al.
Pubblicazione: (2024)

Bruceine A Inhibits Cell Proliferation by Targeting the USP13/PARP1 Signalling Pathway in Multiple Myeloma
di: Mengjie Guo, et al.
Pubblicazione: (2025)

A study of the genotoxicity, fertility and early embryonic development toxicity of rotigotine behenate extended‐release microspheres
di: Xinyu Zhao, et al.
Pubblicazione: (2024)

Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol‐Inspired Approach
di: Tianyi Yu, et al.
Pubblicazione: (2026)

sGC stimulator (BAY 41‐8543) combined with PDE9 inhibitor (BAY 73‐6691) reduces renal fibrosis in 5/6 nephrectomized rats
di: Xin Chen, et al.
Pubblicazione: (2024)

Huoxin Pill Ameliorates Atrial Fibrillation by Modulating Autonomic Nervous Balance and Electrical Conduction Heterogeneity: Insights From Systems Pharmacology and Experimental Validation
di: Mimi Huang, et al.
Pubblicazione: (2025)

Insights Into Gut Barrier Dysfunction and Metabolic Alterations in Mycophenolate‐Induced Enteropathy
di: Clarisse Brossier, et al.
Pubblicazione: (2026)

Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case–Control Study
di: Barkat Babar, et al.
Pubblicazione: (2026)

Eugenol Alleviates Cerebral Ischemia–Reperfusion Injury in Mice by Promoting the Phagocytosis of Microglia via Up‐Regulating Tripartite Motif Protein 59
di: Mengtian Pan, et al.
Pubblicazione: (2025)